Skip to content
AnalystLens

James Hardie Industries 8-K Report (Jun 20, 2025)

Filing Date
Filed June 20, 2025
Period End
June 20, 2025
Securities
JHXJHIUF
In the record · 2016–202610-K1210-Q18-K401

JHX filed 12 annual reports (10-K), 1 quarterly reports (10-Q) and 401 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Oct ’26Oct ’26

Summary

Summary of the 6-K filed June 20, 2025. Cited figures are marked; the original filing is the authoritative source.

James Hardie Industries PLC filed this Form 6-K on June 20, 2025 to furnish two Australian Securities Exchange (ASX) notices covering equity issued under its employee incentive plans.

The filing contains no financial results, guidance or balance sheet data. Its substance is routine capital administration: the issuance and quotation of securities tied to employee compensation. The first exhibit, an Appendix 2A application dated June 13, 2025, seeks quotation of 1,998 CHESS Depositary Interests (CDIs), each 1:1 with the ordinary shares, issued on June 10, 2025 under an employee incentive scheme for no cash consideration.

Following that quotation, the filing states 429,858,477 CDIs on issue, 3,512,772 unquoted restricted stock units (RSUs) and 269,221 unquoted options expiring November 3, 2027 with an exercise price of US$33.05a. The second exhibit, an Appendix 3G dated June 17, 2025, notifies the issue of 582,736 RSUs on June 12, 2025. The grant comprises 2,500 RSUs under the 2001 Plan, 579,908 Relative Integration Incentive RSUs under the 2006 LTI Plan and 328 European EBIT RSUs.

It lists grants to seven key management personnel, including Rachel Wilson (150,058) and Sean Gadd (137,553). After this issue, the filing states 4,095,508 unquoted RSUs on issue. The cautionary statement in the filing also references the proposed AZEK merger among its risk factors.

Key Highlights

  1. Issued 1,998 CHESS Depositary Interests (1:1) on June 10, 2025 under an employee incentive scheme, with no cash consideration, as set out in the Appendix 2A dated June 13, 2025.
  2. Issued 582,736 restricted stock units on June 12, 2025, notified in an Appendix 3G dated June 17, 2025, including 579,908 Relative Integration Incentive RSUs under the 2006 LTI Plan.
  3. Total CDIs on issue are stated as 429,858,477 following the quotation of the 1,998 CDIs.
  4. Unquoted RSUs on issue are stated as 3,512,772 in the Appendix 2A and 4,095,508 after the June 12, 2025 issuance in the Appendix 3G.
  5. Unquoted options expiring November 3, 2027 with an exercise price of US$33.05 total 269,221 and are unchanged across both notices.
  6. Seven key management personnel received RSU grants, led by Rachel Wilson with 150,058 and Sean Gadd with 137,553.
  7. The issuances were made under Listing Rule 7.2 exception 13, so no security holder approval under Listing Rule 7.1 was required, according to both notices.

Frequently Asked Questions

  1. Does this filing include financial results or guidance?

    No. The filing consists of two ASX appendices covering employee equity issuances, and it contains no financial results, revenue, earnings or guidance figures.

  2. What securities were issued and to whom?

    The filing reports 1,998 CHESS Depositary Interests issued on June 10, 2025 and 582,736 restricted stock units issued on June 12, 2025, both under employee incentive schemes. Seven key management personnel are named as recipients of RSUs in the June 12 grant.

  3. Was any cash consideration received for these securities?

    No. The Appendix 2A states the CDIs were not issued for cash, with consideration described as not applicable and an estimated value of 0.000000 AUD per security.

  4. What is the total equity outstanding after these issuances?

    The filing states 429,858,477 quoted CDIs on issue, along with 4,095,508 unquoted RSUs and 269,221 unquoted options after the June 12, 2025 issuance.

  5. Does the filing discuss the proposed AZEK merger?

    Only in the cautionary statement, where the proposed AZEK merger is listed among the factors that could cause actual results to differ from forward-looking statements. The filing does not describe the merger's terms or status.